MYCN-driven high-risk NBs may enhance the eIF4F translation machinery to sustain tumor growth and metastasis, and elevated expression of eIF4A1, eIF4E1, and eIF4G1 correlate with poor prognosis. Here, EIF4E is linked to neoplasm.